期刊
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS
卷 21, 期 6, 页码 971-979出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1871530320666200910105612
关键词
Berberine; metabolic disorders; insulin resistance; chronic inflammatory; type 2 diabetes; nonalcoholic fatty liver disease; intestinal flora
Berberine, extracted from Coptis chinensis, demonstrates various properties like anti-hyperglycemia, anti-obesity, and anti-inflammation, with the ability to improve insulin resistance and regulate intestinal flora. Given the growing prevalence of metabolic disorders and diseases globally, Berberine's metabolic properties show potential for effectively treating metabolic diseases.
Berberine (BBR) is a botanic alkaloid extracted from Coptis chinensis (Huanglian), which has various properties, compassing anti-hyperglycemia, anti-obesity, anti-inflammation, and improves insulin resistance, etc. Several researches have confirmed that BBR has effective actions in treating glycolipid metabolic abnormalities. BBR is also beneficial in regulating intestinal flora. Metabolic diseases are strongly associated with metabolic disorders, which are growing in the population and dramatically impacting human health, which also have been considered as a leading cause of diseases and death globally. This review is to evaluate the metabolic properties of BBR, and its potential application to the treatment of metabolic diseases by its effective actions on metabolic disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据